A carregar...
HIT-Cas9: A CRISPR/Cas9 Genome-Editing Device under Tight and Effective Drug Control
The CRISPR/Cas9 enabled efficient gene editing in an easy and programmable manner. Controlling its activity in greater precision is desired for biomedical research and potential therapeutic translation. Here, we engrafted the CRISPR/Cas9 system with a mutated human estrogen receptor (ER(T2)), which...
Na minha lista:
| Publicado no: | Mol Ther Nucleic Acids |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Gene & Cell Therapy
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6178243/ https://ncbi.nlm.nih.gov/pubmed/30312845 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtn.2018.08.022 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|